| Year |
Citation |
Score |
| 2024 |
Gnanapragasam A, Kirbizakis E, Li A, White KH, Mortenson KL, Cavalcante de Moura J, Jawhar W, Yan Y, Falter R, Russett C, Giannias B, Camilleri-Broët S, Bertos N, Cools-Lartigue J, Garzia L, et al. HiChIP-based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 that Confers Genetic Susceptibility to Gastroesophageal Cancer. Cancer Research. PMID 38748784 DOI: 10.1158/0008-5472.CAN-23-2397 |
0.578 |
|
| 2023 |
Flores-Torres S, Dimitriou NM, Pardo LA, Kort-Mascort J, Pal S, Peza-Chavez O, Kuasne H, Berube J, Bertos N, Park M, Mitsis GD, Ferri L, Sangwan V, Kinsella JM. Bioprinted Multicomponent Hydrogel Co-culture Tumor-Immune Model for Assessing and Simulating Tumor-Infiltrated Lymphocyte Migration and Functional Activation. Acs Applied Materials & Interfaces. PMID 37404007 DOI: 10.1021/acsami.3c02995 |
0.613 |
|
| 2023 |
Evaristo G, Katz A, Ramírez-GarcíaLuna JL, Issac MSM, Sangwan V, Thai DV, Bertos N, Guiot MC, Camilleri-Broët S, Marcus V, Mueller C, Cools-Lartigue J, Fiset PO, Ferri LE. Relation between mismatch repair status, chemoresponse, survival and anatomic location in gastroesophageal adenocarcinoma. Canadian Journal of Surgery. Journal Canadien De Chirurgie. 66: E79-E87. PMID 36792128 DOI: 10.1503/cjs.017021 |
0.533 |
|
| 2023 |
Flores-Torres S, Jiang T, Kort-Mascort J, Yang Y, Peza-Chavez O, Pal S, Mainolfi A, Pardo LA, Ferri L, Bertos N, Sangwan V, Kinsella JM. Constructing 3D In Vitro Models of Heterocellular Solid Tumors and Stromal Tissues Using Extrusion-Based Bioprinting. Acs Biomaterials Science & Engineering. PMID 36598339 DOI: 10.1021/acsbiomaterials.2c00998 |
0.584 |
|
| 2022 |
Al-Marzouki L, Stavrakos VS, Pal S, Giannias B, Bourdeau F, Rayes R, Bertos N, Najmeh S, Spicer JD, Cools-Lartigue J, Bailey SD, Ferri L, Sangwan V. Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 36059037 DOI: 10.1007/s10120-022-01338-1 |
0.593 |
|
| 2022 |
Gómez-Cuadrado L, Bullock E, Mabruk Z, Zhao H, Souleimanova M, Noer PR, Turnbull AK, Oxvig C, Bertos N, Byron A, Dixon JM, Park M, Haider S, Natrajan R, Sims AH, et al. Characterisation of the Stromal Microenvironment in Lobular Breast Cancer. Cancers. 14. PMID 35205651 DOI: 10.3390/cancers14040904 |
0.35 |
|
| 2021 |
Sangwan V, Al-Marzouki L, Pal S, Stavrakos V, Alzahrani M, Antonatos D, Nevo Y, Camilleri-Broët S, Rayes R, Bourdeau F, Giannias B, Bertos N, Bailey S, Rousseau S, Cools-Lartigue J, et al. Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis. Clinical & Experimental Metastasis. PMID 34767138 DOI: 10.1007/s10585-021-10133-8 |
0.6 |
|
| 2020 |
Mohammad AH, Kim SH, Bertos N, El-Assaad W, Nandi I, Smith H, Yang J, Chen O, Gamache I, Rao T, Gagnon B, Gruosso T, Tremblay ML, Sonenberg N, Guiot MC, et al. Elevated V-ATPase activity following PTEN loss is required for enhanced oncogenic signaling in breast cancer. Molecular Cancer Research : McR. PMID 32587106 DOI: 10.1158/1541-7786.Mcr-20-0088 |
0.407 |
|
| 2020 |
Savage P, Pacis A, Kuasne H, Liu L, Lai D, Wan A, Dankner M, Martinez C, Muñoz-Ramos V, Pilon V, Monast A, Zhao H, Souleimanova M, Annis MG, Aguilar-Mahecha A, ... ... Bertos NR, et al. Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors. Communications Biology. 3: 310. PMID 32546838 DOI: 10.1038/s42003-020-1042-x |
0.344 |
|
| 2019 |
Rayes RF, Mouhanna JG, Nicolau I, Bourdeau F, Giannias B, Rousseau S, Quail D, Walsh L, Sangwan V, Bertos N, Cools-Lartigue J, Ferri LE, Spicer JD. Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects. Jci Insight. 5. PMID 31343990 DOI: 10.1172/Jci.Insight.128008 |
0.677 |
|
| 2019 |
Gruosso T, Gigoux M, Manem VSK, Bertos N, Zuo D, Perlitch I, Saleh SMI, Zhao H, Souleimanova M, Johnson RM, Monette A, Ramos VM, Hallett MT, Stagg J, Lapointe R, et al. Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers. The Journal of Clinical Investigation. PMID 30753167 DOI: 10.1172/Jci96313 |
0.407 |
|
| 2019 |
Xue Y, Meehan B, Macdonald E, Venneti S, Wang XQD, Witkowski L, Jelinic P, Kong T, Martinez D, Morin G, Firlit M, Abedini A, Johnson RM, Cencic R, Patibandla J, ... ... Bertos N, et al. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. Nature Communications. 10: 558. PMID 30718512 DOI: 10.1038/S41467-018-06958-9 |
0.389 |
|
| 2019 |
Rayes RF, Mouhanna JG, Nicolau I, Vourtzoumis P, Wong C, Eustache J, Giannias B, Siblini A, Lee E, Sangwan V, Rousseau S, Quail D, Walsh L, Bertos N, Cools-Lartigue J, et al. Abstract 1508: Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects Immunology. DOI: 10.1158/1538-7445.Sabcs18-1508 |
0.629 |
|
| 2019 |
Rayes RF, Mouhanna JG, Wang C, Milette S, Wong C, Usatii M, Giannias B, Mot R, Chandrasekaran A, Moraes C, Huang S, Quail D, Walsh L, Sangwan V, Bertos N, et al. Abstract 2799: Targeting CXCR2-mediated neutrophil recruitment to lung cancer Cancer Research. 79: 2799-2799. DOI: 10.1158/1538-7445.Am2019-2799 |
0.649 |
|
| 2019 |
De Meo M, Rayes R, Milette S, Vagai M, Usatii M, Chandrasekaran A, Giannias B, Bourdeau F, Moraes C, Huang S, Quail D, Walsh L, Sangwan V, Bertos N, Camilleri-Broet S, et al. MA04.07 Inhibition of CXCR2+ Neutrophil Migration as a Targeted Therapy in KRAS-Driven Lung Adenocarcinoma Journal of Thoracic Oncology. 14: S262-S263. DOI: 10.1016/J.Jtho.2019.08.525 |
0.578 |
|
| 2018 |
Hirukawa A, Smith HW, Zuo D, Dufour CR, Savage P, Bertos N, Johnson RM, Bui T, Bourque G, Basik M, Giguère V, Park M, Muller WJ. Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program. Nature Communications. 9: 2547. PMID 29959321 DOI: 10.1038/S41467-018-04864-8 |
0.417 |
|
| 2018 |
Gruosso T, Gigoux M, Bertos N, Manem V, Zuo D, Saleg S, Souleimanova M, Zhao H, Johnson R, Monette A, Ramos VM, Hallett M, Stagg J, Lapointe R, Omeroglu A, et al. Abstract PD6-05: Distinct tumor microenvironments stratify triple negative breast cancer into immune subtypes Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd6-05 |
0.437 |
|
| 2018 |
Janeiro CA, Stavrakos V, Alzahrani M, Rayes RF, Giannias B, Bertos N, Sangwan V, Cools-Lartigue J, Spicer JD, Ferri LE. Abstract 5176: Cell free malignant ascites fluid facilitates gastric adenocarcinoma peritoneal metastasis Cancer Research. 78: 5176-5176. DOI: 10.1158/1538-7445.Am2018-5176 |
0.396 |
|
| 2018 |
Wang C, Rayes R, Mouhanna J, Giannias B, Chandrasekaran A, Mot R, Moraes C, Huang S, Cools-Lartigue J, Bertos N, Ferri L, Spicer J. Abstract 1099: Molecular drivers of neutrophil recruitment to primary non-small cell lung cancer Cancer Research. 78: 1099-1099. DOI: 10.1158/1538-7445.Am2018-1099 |
0.444 |
|
| 2018 |
Kuasne H, Savage P, Ramirez CM, Liu L, Muñoz-Ramos V, Pilon V, Monast A, Johnson R, Bertos N, Asselah J, Bouganim N, Petrecca K, Meterissian S, Omeroglu A, Basik M, et al. Abstract 1044: Establishment and characterization of rare breast patient-derived xenograft models as a potential resource for personalized medicine Cancer Research. 78: 1044-1044. DOI: 10.1158/1538-7445.Am2018-1044 |
0.412 |
|
| 2017 |
Savage P, Blanchet-Cohen A, Revil T, Badescu D, Saleh SMI, Wang YC, Zuo D, Liu L, Bertos NR, Munoz-Ramos V, Basik M, Petrecca K, Asselah J, Meterissian S, Guiot MC, et al. A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer. Cell Reports. 21: 1140-1149. PMID 29091754 DOI: 10.1016/J.Celrep.2017.10.015 |
0.384 |
|
| 2017 |
Saleh SM, Bertos NR, Gruosso T, Gigoux M, Souleimanova M, Zhao H, Omeroglu A, Hallett MT, Park M. Identification of interacting stromal axes in triple-negative breast cancer. Cancer Research. PMID 28652250 DOI: 10.1158/0008-5472.Can-16-3427 |
0.434 |
|
| 2017 |
Liu H, Dowdle JA, Khurshid S, Sullivan NJ, Bertos N, Rambani K, Mair M, Daniel P, Wheeler E, Tang X, Toth K, Lause M, Harrigan ME, Eiring K, Sullivan C, et al. Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation. Developmental Cell. 41: 392-407.e6. PMID 28535374 DOI: 10.1016/J.Devcel.2017.04.024 |
0.413 |
|
| 2017 |
Savage P, Saleh S, Wang Y, Revil T, Badescu D, Liu L, Iacucci E, Zuo D, Bertos N, Munoz-Ramos V, Asselah J, Meterissian S, Omeroglu A, Hébert S, Kleinman C, et al. Abstract P1-06-11: A targetable EGFR-driven tumor-initiating program in breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-06-11 |
0.411 |
|
| 2017 |
Gruosso T, Gigoux M, Bertos N, Manem V, Guiot M, Buisseret L, Salgado R, Van den Eyden G, Haibe-Kains B, Park M. Distinct immune microenvironments stratify triple-negative breast cancer and predict outcome Annals of Oncology. 28: i16. DOI: 10.1093/Annonc/Mdx140.006 |
0.344 |
|
| 2016 |
Bertos NR, Park M. Laser Capture Microdissection as a Tool to Study Tumor Stroma. Methods in Molecular Biology (Clifton, N.J.). 1458: 13-25. PMID 27581011 DOI: 10.1007/978-1-4939-3801-8_2 |
0.386 |
|
| 2016 |
Saleh S, Gruosso T, Gigoux M, Bertos N, Omeroglu A, Zuo D, Meterissian S, Hallett M, Park M. Abstract IA23: Deconvolution of the triple-negative breast cancer microenvironment Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Ia23 |
0.456 |
|
| 2016 |
Gruosso T, Gigoux M, Bertos N, Saleh S, Omeroglu A, Zuo D, Zhao H, Souleimanova M, Weaver V, Meterissian S, Hallett M, Park M. Abstract A15: Mechanisms of CD8+ T cell immunosuppression in triple negative breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-A15 |
0.425 |
|
| 2016 |
Thompson C, Saleh SM, Bertos N, Gigoux M, Gruosso T, Souleimanova M, Zhao H, Hallett MT, Park M. Abstract 720: Novel prognostic stromal subtypes in triple-negative breast cancer Cancer Research. 76: 720-720. DOI: 10.1158/1538-7445.Am2016-720 |
0.467 |
|
| 2015 |
Oh EY, Christensen SM, Ghanta S, Jeong JC, Bucur O, Glass B, Montaser-Kouhsari L, Knoblauch NW, Bertos N, Saleh SM, Haibe-Kains B, Park M, Beck AH. Extensive rewiring of epithelial-stromal co-expression networks in breast cancer. Genome Biology. 16: 128. PMID 26087699 DOI: 10.1186/S13059-015-0675-4 |
0.379 |
|
| 2015 |
You L, Yan K, Zou J, Zhao H, Bertos NR, Park M, Wang E, Yang XJ. The chromatin regulator Brpf1 regulates embryo development and cell proliferation. The Journal of Biological Chemistry. 290: 11349-64. PMID 25773539 DOI: 10.1074/Jbc.M115.643189 |
0.328 |
|
| 2015 |
Gigoux M, Gruosso T, Bertos N, Saleh S, Omeroglu A, Zhao H, Souleimanova M, Meterissian S, Hallett M, Park M. Abstract A69: The immunological environment in triple negative breast cancer; impact on clinical outcomes towards a prognostic clinical test Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A69 |
0.437 |
|
| 2015 |
Thompson C, Bertos N, Gruosso T, Finak G, Lesurf R, Saleh SM, Zhao H, Souleimanova M, Meterissian S, Omeroglu A, Hallett MT, Park M. Abstract P4-04-01: A new breast cancer classification scheme based on novel classes of tumor stroma Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-04-01 |
0.426 |
|
| 2015 |
Saleh SM, Savage P, Laferrière J, Cory S, Bertos N, Souleimanova M, Zhao H, Zacksenhaus E, Muller W, Hallett M, Park M. Abstract A79: Mouse models of breast cancer identify oncogene-associated stroma subtypes Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-A79 |
0.446 |
|
| 2015 |
Savage P, Saleh SM, Iacucci E, Revil T, Wang Y, Bertos N, Monast A, Zhao H, Souleimanova M, Szulwach K, Batchu C, Omeroglu A, Park M, Ragoussis I. Abstract LB-129: Identifying tumor subpopulations and the functional consequences of intratumor heterogeneity using single-cell profiling of breast cancer patient-derived xenografts Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-129 |
0.481 |
|
| 2014 |
Tofigh A, Suderman M, Paquet ER, Livingstone J, Bertos N, Saleh SM, Zhao H, Souleimanova M, Cory S, Lesurf R, Shahalizadeh S, Garcia Lopez N, Riazalhosseini Y, Omeroglu A, Ursini-Siegel J, et al. The prognostic ease and difficulty of invasive breast carcinoma. Cell Reports. 9: 129-42. PMID 25284793 DOI: 10.1016/J.Celrep.2014.08.073 |
0.334 |
|
| 2014 |
Lai AZ, Cory S, Zhao H, Gigoux M, Monast A, Guiot MC, Huang S, Tofigh A, Thompson C, Naujokas M, Marcus VA, Bertos N, Sehat B, Perera RM, Bell ES, et al. Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer. Science Signaling. 7: ra38. PMID 24757178 DOI: 10.1126/Scisignal.2004839 |
0.395 |
|
| 2013 |
Lai A, Cory S, Zhao H, Sehat B, Tofigh A, Guiot M, Thompson C, Bell ES, Bertos N, Ferri LE, Hallett M, Park M. Abstract B69: Dynamic reprogramming of signaling following Met inhibition reveals pathways for cell proliferation and negative feedback in gastric cancer. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B69 |
0.392 |
|
| 2012 |
Mourskaia AA, Amir E, Dong Z, Tiedemann K, Cory S, Omeroglu A, Bertos N, Ouellet V, Clemons M, Scheffer GL, Park M, Hallett M, Komarova SV, Siegel PM. ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone. Breast Cancer Research : Bcr. 14: R149. PMID 23174366 DOI: 10.1186/Bcr3361 |
0.376 |
|
| 2012 |
Pepin F, Bertos N, Laferrière J, Sadekova S, Souleimanova M, Zhao H, Finak G, Meterissian S, Hallett MT, Park M. Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypes. Breast Cancer Research : Bcr. 14: R120. PMID 22906178 DOI: 10.1186/Bcr3246 |
0.45 |
|
| 2012 |
Bertos N, Finak G, Lesurf R, Saleh S, Zhao H, Souleimanova M, Meterrisian S, Omeroglu A, Hallett M, Park M. Abstract ES8-2: Breast Cancer Stroma: A Predictor of Clinical Outcome and Tumour Heterogeneity Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Es8-2 |
0.439 |
|
| 2011 |
Sangwan V, Abella J, Lai A, Bertos N, Stuible M, Tremblay ML, Park M. Protein-tyrosine phosphatase 1B modulates early endosome fusion and trafficking of Met and epidermal growth factor receptors. The Journal of Biological Chemistry. 286: 45000-13. PMID 22045810 DOI: 10.1074/Jbc.M111.270934 |
0.587 |
|
| 2011 |
Bertos NR, Park M. Breast cancer - one term, many entities? The Journal of Clinical Investigation. 121: 3789-96. PMID 21965335 DOI: 10.1172/Jci57100 |
0.423 |
|
| 2011 |
Tabariès S, Dong Z, Annis MG, Omeroglu A, Pepin F, Ouellet V, Russo C, Hassanain M, Metrakos P, Diaz Z, Basik M, Bertos N, Park M, Guettier C, Adam R, et al. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene. 30: 1318-28. PMID 21076473 DOI: 10.1038/Onc.2010.518 |
0.401 |
|
| 2010 |
Eichner LJ, Perry MC, Dufour CR, Bertos N, Park M, St-Pierre J, Giguère V. miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. Cell Metabolism. 12: 352-61. PMID 20889127 DOI: 10.1016/J.Cmet.2010.09.002 |
0.323 |
|
| 2010 |
Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M, Gaboury L, Siegel PM. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2147-56. PMID 20215530 DOI: 10.1158/1078-0432.Ccr-09-1611 |
0.416 |
|
| 2010 |
Rose A, Grosset A, Dong Z, Bertos N, Simantov R, Park M, Gaboury L, Siegel P. Abstract A8: GPNMB is an independent prognostic indicator of recurrence and a therapeutic target in triple negative breast cancer Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcme10-A8 |
0.425 |
|
| 2009 |
Finak G, Bertos N, Hallett M, Park M. Stromal signature identifies basal breast cancers Nature Medicine. 15: 238. DOI: 10.1038/Nm0309-238A |
0.356 |
|
| 2008 |
Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M. Stromal gene expression predicts clinical outcome in breast cancer. Nature Medicine. 14: 518-27. PMID 18438415 DOI: 10.1038/Nm1764 |
0.418 |
|
| 2001 |
Lai A, Kennedy BK, Barbie DA, Bertos NR, Yang XJ, Theberge MC, Tsai SC, Seto E, Zhang Y, Kuzmichev A, Lane WS, Reinberg D, Harlow E, Branton PE. RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Molecular and Cellular Biology. 21: 2918-32. PMID 11283269 DOI: 10.1128/Mcb.21.8.2918-2932.2001 |
0.324 |
|
| Show low-probability matches. |